Bharat Biotech International Limited is an Indian biotechnology company headquartered in Hyderabad, India engaged in the drug discovery, drug development, manufacture of vaccines, bio-therapeutics, pharmaceuticals and health care products. Read More
World Health Organisation (WHO) has extended giving the emergency use authorization for Hyderabad-based Bharat Biotech's COVID-19 vaccine Covaxin to next week. ...
The decision on Bharat Biotech's Covid-19 vaccine, Covaxin Emergency Use Listing (EUL) by the World Health Organisation (WHO) is expected in October, informed the top health experts in the country on Saturday. ...
India would have 27-28 crore COVID-19 vaccine doses of Serum Institute of India's Covishield and Bharat Biotech's Covaxin in the month of October, said government sources. ...
The World Health Organisation (WHO) on Wednesday informed that the final decision on Bharat Biotech's submission on emergency use listing (EUL) for its Covaxin COVID-19 vaccine will be made in October 2021. ...
The emergency use authorisation (EUA) for Bharat Biotech's COVID-19 vaccine Covaxin has once again been delayed by the World Health Organisation, said sources. ...
Bharat Biotech on Friday said it has submitted all the data to the World Health Organisation (WHO) for Emergency Use Listing (EUL) of its COVID-19 vaccine Covaxin and is awaiting feedback from the UN Public Health Agency. ...
Kerala has passed its COVID-19 peak and in the next 2 weeks, a decline in cases should start in the state, said Dr Sanjay Rai, AIIMS Professor on Tuesday. ...
The approval of Bharat Biotech's COVID-19 vaccine Covaxin for Emergency use Listing (EUL) from the World Health Organisation (WHO) is expected at any time soon, said Dr VK Paul, NITI Aayog member (Health) on Tuesday. ...
